Table 3 Subgroup analysis of the association of SUA with the risk of CRC.
From: The relationship between serum uric acid and colorectal cancer: a prospective cohort study
T1 group | T2 group | T3 group | ||||
|---|---|---|---|---|---|---|
Case/person-years | Adjusted HRs (95% CI) | Case/person-years | Adjusted HRs (95% CI) | Case/person-years | Adjusted HRs (95% CI) | |
Sex | ||||||
Womena | 22/78,877 | Ref | 30/79,804 | 1.07 (0.62, 1.87) | 32/76,883 | 1.25 (0.72, 2.17) |
Menb | 142/306,682 | Ref | 158/303,602 | 1.11 (0.90, 1.38) | 199/296,223 | 1.58 (1.10, 2.51) |
p for interaction | 0.962 | |||||
Age (years) | ||||||
Age ≤ 45 | 17/133,763 | Ref | 19/118,813 | 1.82 (0.96, 3.44) | 21/108,964 | 2.00 (1.10, 3.64) |
45 < Age ≤ 65 | 114/218,372 | Ref | 119/223,301 | 1.55 (0.87, 2.99) | 147/201,233 | 1.76 (1.22, 2.14) |
Age > 65 | 33/33,424 | Ref | 50/41,294 | 1.68 (0.64, 4.42) | 63/62,909 | 1.70 (0.68, 4.26) |
p for interaction | 0.338 | |||||
BMI (kg/m2) | ||||||
BMI < 24 | 83/228,576 | Ref | 82/188,049 | 1.82 (0.96, 3.44) | 83/132,987 | 1.98 (1.08, 3.60) |
24 ≤ BMI < 28 | 63/125,979 | Ref | 70/137,704 | 1.20 (0.66, 2.20) | 87/157,283 | 1.21 (0.69, 2.13) |
BMI ≥ 28 | 18/31,004 | Ref | 36/57,653 | 1.68 (0.64, 4.42) | 61/82,836 | 1.78 (0.73, 4.29) |
p for interaction | 0.951 | |||||